Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

PURPOSE: Conventional wisdom has rendered patients with brain metastases ineligible for clinical trials for fear that poor survival could mask the benefit of otherwise promising treatments. Our group previously published the diagnosis-specific Graded Prognostic Assessment (GPA). Updates with larger...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Sperduto, Paul W., Mesko, Shane, Li, Jing, Cagney, Daniel, Aizer, Ayal, Lin, Nancy U., Nesbit, Eric, Kruser, Tim J., Chan, Jason, Braunstein, Steve, Lee, Jessica, Kirkpatrick, John P., Breen, Will, Brown, Paul D., Shi, Diana, Shih, Helen A., Soliman, Hany, Sahgal, Arjun, Shanley, Ryan, Sperduto, William A., Lou, Emil, Everett, Ashlyn, Boggs, Drexell H., Masucci, Laura, Roberge, David, Remick, Jill, Plichta, Kristin, Buatti, John M., Jain, Supriya, Gaspar, Laurie E., Wu, Cheng-Chia, Wang, Tony J.C., Bryant, John, Chuong, Michael, An, Yi, Chiang, Veronica, Nakano, Toshimichi, Aoyama, Hidefumi, Mehta, Minesh P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655019/
https://ncbi.nlm.nih.gov/pubmed/32931399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.01255
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados